Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir

P. Bonfanti, G. Madeddu, R. Gulminetti, N. Squillace, G. Orofino, P. Vitiello, S. Rusconi, B. M. Celesia, P. Maggi, E. Ricci, CISAI Study group

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)455-457
Number of pages3
JournalAIDS (London, England)
Volume31
Issue number3
DOIs
Publication statusPublished - Jan 28 2017

Cite this

Bonfanti, P., Madeddu, G., Gulminetti, R., Squillace, N., Orofino, G., Vitiello, P., Rusconi, S., Celesia, B. M., Maggi, P., Ricci, E., & group, CISAI. S. (2017). Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir. AIDS (London, England), 31(3), 455-457. https://doi.org/10.1097/QAD.0000000000001351 [doi]